Whether it’s the high cost of insulin or the question of when to start combination therapy, the new issue of Evidence-Based Diabetes Management, a publication of The American Journal of Managed Care, covers up-to-the-minute topics in this special issue on therapeutics. Editor-in-chief Robert A. Gabbay, MD, PhD, FACP, leads off this issue featuring voices of providers, pharmaceutical leaders, payers, and patients.
The new guideline comes as FDA weighs an advisory panel recommendation for CGM dosing, which many see as a first step toward Medicare coverage.
A series of papers in The Lancet highlights how city planning and urban design can prevent chronic diseases and create healthier and more sustainable cities.
Second of 2 parts: Coverage of the first half of the session appeared in the May issue of Evidence-Based Diabetes Management.1
Second of 2 Parts: See Part 1, in Evidence-Based Diabetes Management, coverage of Patient-Centered Diabetes Care 2016.


April 12th, 2014
Hershey, PA
May 22nd to 25th , 2014
Fort Lauderdale, FL
August 14th to 16th, 2014
Stowe, VT
Diabetes Compendium
HCV Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium